Sepul Bio begins clinical trial of ultevursen for USH2A-associated RP
Sepul Bio begins clinical trial of ultevursen for USH2A-associated RP
Search
Search results
Therapy development updates
There are many ongoing clinical and laboratory studies around the world, exploring innovative approaches to treating inherited sight loss.
Webinar: Inflammation and retinal degeneration in RP
Inflammation and retinal degeneration in retinitis pigmentosa: Can lessons learned in the lab help us identify treatments in the clinic?
Webinar: Mark Goes to Las Vegas
Listen to our webinar to hear about our Information and Support Coordinator, Mark Baxter's, holiday in Las Vegas.
CRISPR Gene Editing Leads to Improvements
CRISPR gene editing leads to improvements in vision for people with inherited blindness, clinical trial shows.
Webinar: Mark Goes to Las Vegas
Join our upcoming webinar to hear about our Information and Support Coordinator, Mark Baxter's, holiday in Las Vegas.
Together We Can: ways you can get involved!
Join our upcoming webinar to find out how you can get involved and fundraise for Retina UK this year.
Miles for Vision: Behind the Scenes of the London Marathon 2025
Join our upcoming webinar to hear from our Fundraising manager James Clarke, as he talks to some of our 2025 London Marathon runners!
Meet a researcher: Chloe Brotherton
As part of our aim to nurture young scientists, we are very pleased to introduce one of our new PhD students as part of a co-funding agreement with the Macular Society.
Medical Advisory Board
Our Medical Advisory Board (MAB) advises our Board of Trustees in order that they can approve grants for research projects.